I've been having a lot of conversations lately about GLP-1 medications, and I keep noticing the same thing: people are working with fragments of information, half-remembered headlines, and a lot of genuine anxiety. That's completely understandable, but I think you deserve the full picture.

So let's do some myth-busting.

This one comes up constantly, and the origin makes sense - in rats and mice, GLP-1 drugs do cause tumors in certain thyroid cells (C-cells), because those animals have a lot of GLP-1 receptors there. But human thyroid C-cells have far fewer of those receptors. Large studies following hundreds of thousands of people on GLP-1 drugs haven't shown a clear increase in thyroid cancer. Medullary thyroid cancer remains extremely rare.

Large clinical development programs and post‑marketing data for liraglutide and semaglutide have not shown a consistent increase in medullary thyroid carcinoma incidence, and a 2024 safety review concludes that epidemiologic evidence does not support a causal link, though caution remains in people with MEN2 or personal/family MTC history.

A 2025 JCEM study found that semaglutide did not make human thyroid cancer cells grow in lab tests. Instead, it appeared to shift certain immune cells toward fighting tumors.

The FDA's boxed warning exists, but it's based on animal data, not proven human harm. Current human evidence doesn't support the fear.

This is probably the myth I hear most often. Here's what a 2025 meta-analysis of 22 randomized controlled trials actually found: weight lost on GLP-1 medications is roughly 75% fat, 25% lean mass and the proportion of lean mass relative to body weight stays essentially stable.

That 25% lean mass figure sounds alarming until you compare it to diet-only caloric restriction without resistance training, where you see pretty much the same thing.

The STEP-1 and SURMOUNT-1 trials confirmed this - most of the weight lost was fat. A 2026 study from UC Davis reached the same conclusion: modest skeletal muscle loss, largely preserved strength.

Research shows muscle loss happens with any meaningful weight loss. GLP-1 isn't uniquely bad here. Add protein and resistance training, and the picture looks even better.

Multiple meta-analyses across tens of thousands of patients have found no statistically significant increase in pancreatitis compared to placebo.

A larger 2025 meta‑analysis of 62 RCTs (66,232 patients) reported a modestly elevated relative risk overall, but this lost statistical significance once trials were stratified by background medications, and absolute event rates remained very low (fractions of a percent).

Individual risk assessment still matters, especially if you have a pancreatitis history. But population-level data doesn't support the "it destroys your pancreas” narrative.

GLP-1 does slow gastric emptying - that's real and actually part of how it works. But classic research showed this effect weakens significantly over time, and more recent reviews confirm the slowing is strongest early in treatment and attenuates over weeks to months.

A 2024 peri-operative review found more retained gastric contents at endoscopy in GLP-1 users, but clinically significant aspiration is rare.

Current data doesn't show widespread, irreversible structural damage and most concerns come from case reports, not large controlled trials.

This one's more flattering than scary, but still misleading. GLP-1 medications work primarily by reducing how much you want to eat. They act in the hypothalamus, stimulating the neurons that signal fullness and quieting the ones that drive hunger and cravings. Reduced caloric intake is the dominant mechanism, not thermogenesis.

These are appetite and behavior drugs, not stimulants. GLP1s help you lose weight mainly because you just don't want and don't eat as much, not because they "speed up" your metabolism.

Media articles spread faster than peer-reviewed papers. A single case report gets more shares than a meta-analysis of thousands of patients. And somewhere in between, real people making real health decisions get left with fear and confusion instead of clarity.

I'm not here to tell you GLP-1 is perfect, or that every concern is baseless - medicine is never that simple. So here's what I'd ask of you: next time someone in your life repeats one of these myths, send them this post.

And if you're reading this and there's a myth, a question, or something you're genuinely unsure about - reply and tell me.

If this was useful, subscribe or share it with one person who needs it.